EUVIMEDEUVIMED entdecken
Crossref

Assessment of the Haematological Alterations in Cervical Cancer Patients Attending Sabratha

Azab Elsayed Azab, Fikry Ali Abushofa, Hajar Musa Al Ghawi

Clinical Oncology Research and Reports · 2022

DOI: 10.31579/2693-4787/036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology Research and Reports, 2022. Verfasst von Azab Elsayed Azab und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervix cancer is one of the most common cancers in women worldwide, and is the third most common malignant disease in women. It is one of the main health problems in Libyan women. Blood act as a pathological reflector of the status of exposed patient to infections and other conditions. Laboratory tests on the blood are vital tools that help detect any deviation from normal in the human body As the disease progresses, changes appear in haematological parameters which have been of relevant consideration in context of cancer patients.

Objectives

The present study aimed to evaluate the alterations in haematological parameters among cervical cancer patients in Sabratha National Cancer Institute. Subjects and Methods: The present study was conducted on 150 cervical cancer patients, attending the National Cancer Institute of Sabratha from the 11th February, 2006 to the 3rd February, 2020. This study was approved by the Research and Ethical Committee of Sabratha University and Sabratha National Cancer Institute. Age was extracted from patient files. Also, 60 healthy individuals without any chronic disease were recruited for the control group. Blood samples were collected by vein puncture, 3 ml of venous blood withdrawn from each participant in the study by using disposable syringes under aseptic technique; they then transferred to a sterile EDTA tube, for complete blood count. The statistical significance of differences between groups was evaluated with the Mann Whitney U test.

Results

The results showed that the mean age of the cervix cancer patients was 53.37±11.6 years.RBCs count, hemoglobin concentration, Hct value, MCH, MCHC, and lymphocytes % were significantly (P

Zitieren

APA

Azab, A. E., Abushofa, F. A., & Ghawi, H. M. A. (2022). Assessment of the Haematological Alterations in Cervical Cancer Patients Attending Sabratha. Clinical Oncology Research and Reports. https://doi.org/10.31579/2693-4787/036

Vancouver

Azab AE, Abushofa FA, Ghawi HMA. Assessment of the Haematological Alterations in Cervical Cancer Patients Attending Sabratha. Clinical Oncology Research and Reports. 2022. doi:10.31579/2693-4787/036

BibTeX
@article{Azab2022,
  author = {Azab, Azab Elsayed and Abushofa, Fikry Ali and Ghawi, Hajar Musa Al},
  title = {Assessment of the Haematological Alterations in Cervical Cancer Patients Attending Sabratha},
  journal = {Clinical Oncology Research and Reports},
  year = {2022},
  doi = {10.31579/2693-4787/036}
}
Kostenlos starten →